Humle Småbolagsfond vs UBS Lux Equity Fund Biotech USD

Humle Småbolagsfond vs UBS Lux Equity Fund Biotech USD

1. Humle Småbolagsfond

  • Security

    Humle Småbolagsfond A

  • Fee

    1.50%

  • ISIN

    SE0002229658

  • Holdings

    14

  • Number of owning funds

    2

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 19 holdings in Humle Småbolagsfond, where the largest holding is Beijer Ref B (4.48), followed by Trelleborg (4) and AAK (3.91). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).

All Holdings

Here we compare the holdings in Humle Småbolagsfond and UBS Lux Equity Fund Biotech USD.

Humle Småbolagsfond UBS Lux Equity Fund Biotech USD
1. Beijer Ref B
Sweden
4.48 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Trelleborg B
Sweden
4 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. AAK Sweden AB
Sweden
3.91 %
3. Moderna Inc
9.21 %
4. Addtech B
Sweden
3.87 %
4. Alnylam Pharmaceuticals Inc
6.54 %
5. Securitas B
Sweden
3.69 %
5. AbbVie Inc
USA
5.52 %
6. Vitec Software Group B
Sweden
3.59 %
6. Gilead Sciences Inc
USA
4.66 %
7. Avanza Bank Holding
Sweden
3.54 %
7. Amgen Inc
4.32 %
8. Sagax B
Sweden
3.31 %
8. BioNTech SE
4.13 %
9. Lagercrantz Group B
Sweden
3.26 %
9. Karuna Therapeutics Inc
3.75 %
10. Fortnox AB
Sweden
3.18 %
10. Royalty Pharma Plc
3.28 %
11. Sectra B
Sweden
3.11 %
-
12. Nordnet Bank AB
Sweden
3.05 %
-
13. Bravida Holding
2.51 %
-
14. Loomis B
Sweden
2.4 %
-

The list of fund holdings was last updated on April 17, 2025.